Sangamo Therapeutics, Inc. (LON:0R1D)
0.3938
-0.0145 (-3.55%)
At close: Jan 23, 2026
Sangamo Therapeutics Market Cap
Sangamo Therapeutics has a market cap or net worth of 99.38 million as of January 23, 2026. Its market cap has decreased by -55.82% in one year.
Market Cap
99.38M
Enterprise Value
96.27M
Revenue
24.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.39
Market Cap Chart
Since April 6, 2000, Sangamo Therapeutics's market cap has increased from 58.46M to 99.38M, an increase of 70.00%. That is a compound annual growth rate of 2.08%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 22, 2026 | 99.38M | -5.36% |
| Dec 31, 2025 | 105.01M | -38.23% |
| Dec 31, 2024 | 169.99M | 124.73% |
| Dec 29, 2023 | 75.64M | -82.29% |
| Dec 30, 2022 | 427.08M | -47.07% |
| Dec 31, 2021 | 806.88M | -50.09% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 209.68B |
| GSK plc | 72.04B |
| Haleon | 32.16B |
| Smith & Nephew | 10.20B |
| Shield Therapeutics | 120.13M |
| Bioventix | 92.74M |
| 4basebio | 91.32M |
| Venture Life Group | 80.27M |